{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:39:31Z","timestamp":1787585971358,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>\n                    Differentiation syndrome (DS) is a potentially life-threatening complication during induction therapy for acute promyelocytic leukemia (APL). Despite therapeutic advances, early identification of patients at high risk for DS remains clinically critical. This study aimed to investigate clinical, laboratory, and treatment-related risk factors associated with DS in patients with newly diagnosed APL. This retrospective observational study included 316 adult patients diagnosed with APL between January 2014 and December 2024. Diagnosis was confirmed by cytomorphology, immunophenotyping, cytogenetics, and detection of the PML-RARA fusion gene. All patients received induction therapy with all-trans retinoic acid, arsenic trioxide, or both. Clinical and laboratory parameters were compared between DS (n\u2005=\u200596) and non-DS (n\u2005=\u2005220) groups. Logistic regression analysis was used to identify independent predictors of DS. The incidence of DS was 30.4%. Compared to the non-DS group, DS patients exhibited significantly higher white blood cell (WBC) counts, neutrophil counts, and percentages of bone marrow and peripheral blood blasts (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Coagulation abnormalities (prolonged prothrombin time, reduced fibrinogen) and hypoalbuminemia were more frequent in the DS group. Multivariate analysis identified 3 independent risk factors: absence of prophylactic corticosteroid use (odds ratio [OR] 0.10, 95% confidence interval [CI] 0.03\u20130.35), elevated peak WBC during induction (OR 1.07, 95% CI 1.03\u20131.11), and lower baseline serum albumin (OR 0.86, 95% CI 0.79\u20130.93). Elevated peak WBC, hypoalbuminemia, and lack of prophylactic corticosteroids are independent predictors of DS in APL patients. These findings underscore the importance of early risk stratification and preventive strategies to mitigate DS risk during induction therapy.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046458","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:01:10Z","timestamp":1765814470000},"page":"e46458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of risk factors for differentiation syndrome in patients with acute promyelocytic leukemia"],"prefix":"10.1097","volume":"104","author":[{"given":"Mingwan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, Zhongshan City People\u2019s Hospital, Zhongshan, Guangdong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongshan City People\u2019s Hospital, Zhongshan, Guangdong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongshan City People\u2019s Hospital, Zhongshan, Guangdong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3753-6859","authenticated-orcid":false,"given":"Ziwen","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongshan City People\u2019s Hospital, Zhongshan, Guangdong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.3390\/cancers15194767","article-title":"Differentiation syndrome in acute leukemia: APL and beyond.","volume":"15","author":"Woods","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.16151","article-title":"Differentiation syndrome in acute promyelocytic leukaemia.","volume":"187","author":"Stahl","year":"2019","journal-title":"Br J Haematol"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.2024024008","article-title":"How I treat acute myeloid leukemia with differentiation therapy.","volume":"145","author":"Issa","year":"2025","journal-title":"Blood"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s10637-025-01556-1","article-title":"Understanding the differentiation syndrome in acute promyelocytic leukemia: a comprehensive updated review.","volume":"43","author":"Damaj","year":"2025","journal-title":"Invest New Drugs"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"e2022027","DOI":"10.4084\/MJHID.2022.027","article-title":"Challenging management of severe differentiation syndrome in pediatric acute promyelocytic leukemia treated with ATRA\/ATO.","volume":"14","author":"Molinaro","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2013-10-512640","article-title":"How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.","volume":"123","author":"Sanz","year":"2014","journal-title":"Blood"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"911745","DOI":"10.3389\/fonc.2022.911745","article-title":"The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.","volume":"12","author":"LaBella","year":"2022","journal-title":"Front Oncol"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41408-024-01074-y","article-title":"Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia.","volume":"14","author":"Wu","year":"2024","journal-title":"Blood Cancer J"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ajh.26142","article-title":"Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia.","volume":"96","author":"Fathi","year":"2021","journal-title":"Am J Hematol"},{"key":"R10-20251215","first-page":"e12042","article-title":"Differentiation syndrome, a side effect from the therapy of acute promyelocytic leukemia.","volume":"12","author":"Reyhanoglu","year":"2020","journal-title":"Cureus"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/bjh.19759","article-title":"Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications.","volume":"205","author":"Cicconi","year":"2024","journal-title":"Br J Haematol"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-117-4-292","article-title":"The \u201cretinoic acid syndrome\u201d in acute promyelocytic leukemia.","volume":"117","author":"Frankel","year":"1992","journal-title":"Ann Intern Med"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2008-07-168617","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.","volume":"113","author":"Montesinos","year":"2009","journal-title":"Blood"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"e2024063","DOI":"10.4084\/MJHID.2024.063","article-title":"Atypical differentiation syndrome with sudden vision loss in acute promyelocytic leukemia treated with ATRA plus ATO: a clinical case.","volume":"16","author":"Boscaro","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R15-20251215","first-page":"e50042","article-title":"A race against time: early-onset differentiation syndrome following all-trans-retinoic-acid (ATRA) Therapy in acute promyelocytic leukemia (AML-M3).","volume":"15","author":"Ahmad","year":"2023","journal-title":"Cureus"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.","volume":"111","author":"de la Serna","year":"2008","journal-title":"Blood"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00277-020-04245-6","article-title":"Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.","volume":"99","author":"Minamiguchi","year":"2020","journal-title":"Ann Hematol"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12672-024-01241-4","article-title":"Clinical characteristics and analysis of related factors associated with early death in newly diagnosed patients with acute promyelocytic leukemia.","volume":"15","author":"Wang","year":"2024","journal-title":"Discov Oncol"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1007\/s00277-024-05776-y","article-title":"Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide.","volume":"103","author":"Gao","year":"2024","journal-title":"Ann Hematol"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"2191462","DOI":"10.1080\/16078454.2023.2191462","article-title":"Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.","volume":"28","author":"Kungwankiattichai","year":"2023","journal-title":"Hematology"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"895777","DOI":"10.3389\/fonc.2022.895777","article-title":"Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia.","volume":"12","author":"Wen","year":"2022","journal-title":"Front Oncol"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1159\/000516798","article-title":"Distinct characteristics of sweet\u2019s syndrome of the scrotum caused by all-trans retinoic acid in a patient with acute promyelocytic leukemia.","volume":"14","author":"Imataki","year":"2021","journal-title":"Case Rep Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:01:13Z","timestamp":1765814473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":22,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046458","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-08-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}